Acurx Pharmaceuticals (ACXP)
(Delayed Data from NSDQ)
$5.05 USD
-0.04 (-0.80%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $5.21 +0.16 (3.18%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Acurx Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ACXP 5.05 -0.04(-0.80%)
Will ACXP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACXP
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
ACXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Other News for ACXP
ACXP Trading Halted as Acurx Pharmaceuticals Awaits News
Acurx Pharmaceuticals trading halted, news pending
Acurx (ACXP) Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing
Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split | ACXP Stock News
Acurx approves 1-for-20 reverse stock split